Shorla Oncology co-founders: ‘We felt compelled to do something meaningful’
One is an ‘adrenalin-seeker’, the other a ‘voice of reason’. Now, after years of ‘serious graft’, EY award-winning pharma entrepreneurs Sharon Cunningham and Orlaith Ryan are poised to expand their portfolio of cancer treatments